New Bone Marrow Test Could Double Survival Rates for Acute Myeloid Leukemia Patients
A groundbreaking UK trial has developed a highly sensitive bone marrow test that can detect returning Acute Myeloid Leukemia up to three months earlier than standard blood tests, potentially doubling survival rates for some patients.
Diabetes Drug Metformin Shows Promise in Preventing Acute Myeloid Leukemia
Cambridge researchers discover that metformin, a widely prescribed diabetes medication, may help prevent acute myeloid leukemia (AML) in high-risk individuals by targeting mutations in the DNMT3A gene.
NHS Approves Breakthrough CAR T-Cell Therapy Liso-cel for Advanced Lymphoma Patients
A groundbreaking CAR T-cell therapy, liso-cel, has been approved by NHS for treating large B-cell lymphoma patients who haven't responded to initial treatment or experienced relapse within 12 months.
Teclistamab Approved for Fourth-Line Myeloma Treatment on NHS in England and Wales
Teclistamab (Tecvayli) has been approved by NICE for fourth-line treatment of multiple myeloma in England and Wales, offering a new option for patients who have exhausted other treatments.